Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001202927 | SCV001374062 | uncertain significance | Thrombophilia due to protein C deficiency, autosomal dominant | 2024-10-31 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 385 of the PROC protein (p.Met385Ile). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of PROC-related conditions (PMID: 8499565, 34650936). This variant is also known as Met343Ile. ClinVar contains an entry for this variant (Variation ID: 934521). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PROC protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
MGZ Medical Genetics Center | RCV001202927 | SCV002581253 | likely pathogenic | Thrombophilia due to protein C deficiency, autosomal dominant | 2021-12-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003313189 | SCV004012245 | uncertain significance | not provided | 2023-01-06 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); Also known as p.M343I; This variant is associated with the following publications: (PMID: 34650936, 8499565) |
Mayo Clinic Laboratories, |
RCV003313189 | SCV004226508 | likely pathogenic | not provided | 2022-02-02 | criteria provided, single submitter | clinical testing | PP3, PM1, PM2, PS4_moderate |
Ce |
RCV003313189 | SCV005042523 | likely pathogenic | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | PROC: PM1, PM2, PS4:Moderate |